Published in Diabetes on December 01, 1981
Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action. Proc Natl Acad Sci U S A (1982) 1.57
The effects of plasma from patients with Graves' disease on foetal mouse hearts in organ culture. Br J Exp Pathol (1983) 0.78
Stimulatory effect of immunoglobulins and Fc fragments on glucose oxidation and glucose transport by adipocytes. Br J Exp Pathol (1985) 0.75
Persistence of parathyroid hypersecretion after vitamin D treatment in Asian vegetarians. J Clin Endocrinol Metab (1984) 2.86
Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab (2000) 2.32
Serum trypsin concentrations in diabetes mellitus. Br Med J (1978) 2.09
Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol (1999) 1.92
Simulating the diabetic environment modifies in vitro prostacyclin synthesis. Diabetes (1983) 1.90
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Serum immunoreactive trypsin in cystic fibrosis. Thorax (1981) 1.68
Serum isoamylase activities in diabetes mellitus. J Clin Pathol (1980) 1.55
Successful treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J (1979) 1.46
Vitamin D nutrition in pregnant women at term and in newly born babies in Saudi Arabia. J Clin Pathol (1984) 1.44
Glycosylated haemoglobin in rheumatoid arthritis. Ann Rheum Dis (1982) 1.42
Role of inflammatory mediators in the suppression of insulin receptor phosphorylation in circulating mononuclear cells of obese subjects. Diabetologia (2006) 1.42
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Re: Effects of prostaglandin E1 on penile erection and erectile failure. J Urol (1988) 1.38
Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese. J Clin Endocrinol Metab (2001) 1.37
Cerebral blood flow in diabetes mellitus: evidence of abnormal cerebrovascular reactivity. Br Med J (1978) 1.33
Low pancreatic lipase in insulin-dependent diabetics. J Clin Pathol (1983) 1.31
Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release. Br Med J (Clin Res Ed) (1983) 1.30
Brachial vascular reactivity in blacks. Hypertension (2000) 1.23
Platelet function defects in chronic alcoholism. Br Med J (Clin Res Ed) (1986) 1.23
Assessment of platelet function in patients with Raynaud's syndrome. J Clin Pathol (1984) 1.22
Effect of nonesterified fatty acids on the stability of prostacyclin activity. Metabolism (1983) 1.22
Exocrine pancreatic function in diabetes mellitus. J Clin Pathol (1984) 1.22
Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (1986) 1.21
Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease. Eur J Clin Invest (1988) 1.20
Osteomalacia presenting as pathological fractures during pregnancy in Asian women of high socioeconomic class. Br Med J (Clin Res Ed) (1985) 1.18
Insulin inhibits NFkappaB and MCP-1 expression in human aortic endothelial cells. J Clin Endocrinol Metab (2001) 1.18
Glycosylated haemoglobin in chronic renal failure. Br Med J (1979) 1.16
Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism (1999) 1.15
Pancreatic exocrine function after truncal and highly selective vagotomy. J Clin Pathol (1981) 1.15
An investigation into the effects of bacterial lipopolysaccharide on human platelets. Eur J Haematol (1989) 1.14
Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med (2000) 1.14
Protection of prostacyclin-like activity in human plasma-a non-enzymatic mechanism? Clin Sci (Lond) (1982) 1.12
The effects of fenfluramine on in vitro platelet aggregation. Br J Clin Pharmacol (1982) 1.12
ATP-evoked Ca2+ mobilisation and prostanoid release from astrocytes: P2-purinergic receptors linked to phosphoinositide hydrolysis. J Neurochem (1989) 1.12
Insulin-like effect of zinc on adipocytes. Diabetes (1980) 1.11
Salivary amylase and pancreatic enzymes in serum after total body irradiation. Clin Chem (1986) 1.10
Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism (2000) 1.09
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand J Immunol (2006) 1.09
Diabetes mellitus after hypophysectomy for acromegaly. Br Med J (Clin Res Ed) (1987) 1.08
Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association. Br Heart J (1985) 1.07
Adrenaline and potassium. Lancet (1984) 1.06
Two tier screen for cystic fibrosis. Lancet (1981) 1.06
Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab (2000) 1.05
Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? J Clin Endocrinol Metab (2001) 1.05
Vascular reactivity in patients with peripheral vascular disease. Am J Cardiol (1995) 1.04
The effect of non-specific beta-blockade on metabolic and haemostatic variables during hypoglycaemia. Diabetes Res (1985) 1.03
Low-dose insulin infusions in diabetic patients with high insulin requirements. Lancet (1978) 1.03
Diminished creatinine clearance in anorexia nervosa: reversal with weight gain. J Clin Pathol (1985) 1.03
Serum pancreatic lipase activity in cystic fibrosis. Br Med J (Clin Res Ed) (1983) 1.02
Prostacyclin-like activity in the female rat thoracic aorta and the inferior vena cava after ethinyloestradiol and norethisterone. Clin Sci (Lond) (1980) 1.01
Calcium, vitamin D and parathyroid hormone relationships in pregnant Caucasian and Asian women and their neonates. Ann Clin Biochem (1987) 1.01
Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis. J Clin Endocrinol Metab (1987) 1.01
Hyperphosphataemic rickets: a new variant. Br Med J (Clin Res Ed) (1983) 1.01
Experimental diabetes mellitus inhibits prostacyclin synthesis by the rat penis: pathological implications. Diabetologia (1985) 1.01
Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res (2000) 1.00
Comparison of the effect of a conventional heparin and a low molecular weight heparinoid on platelet function. Br J Clin Pharmacol (1984) 1.00
Platelet function in patients admitted with a diagnosis of myocardial infarction. Angiology (1987) 1.00
Sperm function and structure and seminal plasma prostanoid concentrations in men with IDDM. Diabetes Care (1990) 0.99
Effects of fish oil supplements in NIDDM subjects. Controlled study. Diabetes Care (1990) 0.99
Size of pancreas in diabetes mellitus: a study based on ultrasound. Br Med J (Clin Res Ed) (1985) 0.98
Warfarin administration increases uric acid concentrations in plasma. Clin Chem (1986) 0.98
Rickets in Nigerian children: a consequence of calcium malnutrition. Metabolism (1991) 0.97
Lipid hydroperoxide stimulates retinal neovascularization in rabbit retina through expression of tumor necrosis factor-alpha, vascular endothelial growth factor and platelet-derived growth factor. Angiogenesis (1998) 0.97
Impaired carboxylation of osteocalcin in warfarin-treated patients. J Clin Endocrinol Metab (1987) 0.97
Serum pancreatic enzymes in the elderly. Ann Clin Biochem (1984) 0.96
Plasma creatinine and creatinine clearance in nutritional osteomalacia. Lancet (1984) 0.96
Insulin resistance and iron overload. Ann Clin Biochem (1983) 0.96
Increased serum pancreatic enzymes after treatment with methylprednisolone: possible evidence of subclinical pancreatitis. Br Med J (Clin Res Ed) (1985) 0.96
Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynaud's syndrome. Prostaglandins Leukot Med (1985) 0.96
The effect of intravenous epoprostenol (prostacyclin, PGI2) on cerebral blood flow and cardiac output in man. Br J Clin Pharmacol (1983) 0.95
Hydrocortisone suppresses intranuclear activator-protein-1 (AP-1) binding activity in mononuclear cells and plasma matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9). J Clin Endocrinol Metab (2001) 0.95
Bilateral abdominal lipohypertrophy after continuous subcutaneous infusion of insulin. Br Med J (Clin Res Ed) (1982) 0.95
Hypothermia and pancreatitis. J Clin Pathol (1983) 0.95
Instability of cerebral blood-flow in insulin-dependent diabetics. Lancet (1979) 0.94
Platelet abnormalities in patients with cystic fibrosis and obligate heterozygotes. Haematologica (1990) 0.94
Inhibitors of platelet aggregation in the fetoplacental unit and myometrium with particular reference to the ADP-degrading property of placenta. Placenta (1981) 0.94
Hypoalbuminaemic hyponatraemia: a new syndrome? Br Med J (Clin Res Ed) (1985) 0.94
Inhibition of platelet aggregation by placental extracts. Thromb Res (1980) 0.94
Plasma histamine concentrations are elevated in patients with diabetes mellitus and peripheral vascular disease. Metabolism (1989) 0.93
Painful diabetic neuropathy. Lancet (1985) 0.93
Heparin-induced platelet aggregation in anorexia nervosa and in severe peripheral vascular disease. Eur J Clin Invest (1985) 0.93
Osteopenia in women with anorexia nervosa. N Engl J Med (1985) 0.92
Insulin receptor antibodies causing steroid responsive diabetes mellitus in a patient with myositis. Br Med J (Clin Res Ed) (1984) 0.92
Effect of diflunisal on in vitro platelet aggregation. Lancet (1980) 0.92
Excitatory receptor-prostanoid synthesis coupling in smooth muscle: mediation by calcium, protein kinase C and G proteins. Prostaglandins Leukot Essent Fatty Acids (1988) 0.92
Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis. Eur J Pharmacol (1985) 0.92
Diphosphonates inhibit human osteoblast secretion and proliferation. Metabolism (1989) 0.91
Low 1,25-dihydroxyvitamin D, secondary hyperparathyroidism, and normal osteocalcin in elderly subjects. J Clin Endocrinol Metab (1986) 0.91
Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa. J Clin Pathol (1988) 0.91
Rapid development and progression of proliferative retinopathy after strict diabetic control. Br Med J (Clin Res Ed) (1985) 0.91
Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects. Hypertension (2000) 0.91
Astrocytes as eicosanoid-producing cells. Glia (1988) 0.91
Adrenergic modulation of vascular prostacyclin (PGI2) secretion. Eur J Pharmacol (1985) 0.90
Human immunoglobulin G stimulates human adipocyte lipogenesis. Diabetologia (1983) 0.90
Vitamin D and parathyroid hormone and bone mineralisation in adults with cystic fibrosis. Thorax (1988) 0.90
Fibrinogen mediated activation of platelet aggregation and thromboxane A2 release: pathological implications in vascular disease. J Clin Pathol (1985) 0.89